Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 43Liver Neoplasms 13Colorectal Neoplasms 11Recurrence 6Neoplasm Metastasis 5Cholangiocarcinoma 5Rupture, Spontaneous 2Postoperative Complications 2Pancreatic Neoplasms 2Colonic Neoplasms 2Tissue Adhesions 1Stomach Neoplasms 1Secondary Malignant Neoplasm of Liver 1Sarcopenia 1Reperfusion Injury 1Obesity, Morbid 1Neoplasms 1Nasopharyngeal Carcinoma 1Metabolic Syndrome 1Long-term Effects of Cancer Treatment 1Liver Surgery 1Liver Failure 1Klatskin Tumor 1Ischemia 1Hypertension, Portal 1Hemangioma 1Focal Nodular Hyperplasia 1Fibrosis 1Disease Progression 1Conversion Disorder 1

Interventions

Cisplatin 21pembrolizumab 16Gemcitabine 16Paclitaxel 15Radiotherapy 14Carboplatin 14Radiotherapy, Intensity-Modulated 13Cyclophosphamide 9Cetuximab 9Magnetic Resonance Spectroscopy 8Radiation 7padeliporfin 6Specimen Handling 6Oxaliplatin 6Fluorouracil 6Drug Therapy 6Docetaxel 6Capecitabine 6Bevacizumab 6anlotinib 5Nivolumab 5Irinotecan 5Erlotinib Hydrochloride 5Celecoxib 5poly ICLC 4fludarabine 4Standard of Care 4Sorafenib 4Leucovorin 4Ipilimumab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Carcinoma × Hepatectomy × Clear all
NCT02102971 2019-09-25

Observational Study of Biomarker During Liver Surgery

University of Florida

Terminated
41 enrolled
Gastrointestinal

Carcinoma, Ischemia, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡